Finance

Lists
Why is 603229 up 2.28%?
Dive Deeper
603229:SHA
Zhejiang Ausun Pharmaceutical Co Ltd
CNÂ¥7.18
+2.28%
(+0.16) 1D
Nov 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603229...
Open
CNÂ¥7.07
High
CNÂ¥7.20
Low
CNÂ¥6.97
Mkt. cap
5.83B
Avg. vol.
6.78M
Volume
6.35M
Dividend
0.89%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 17, 2026
52-wk high
CNÂ¥10.81
52-wk low
CNÂ¥6.83
EPS
-CNÂ¥0.00
Shares outstanding
160.00M
No. of employees
1K
Open
CNÂ¥7.07
High
CNÂ¥7.20
Low
CNÂ¥6.97
Mkt. cap
5.83B
Avg. vol.
6.78M
Volume
6.35M
Dividend
0.89%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 17, 2026
52-wk high
CNÂ¥10.81
52-wk low
CNÂ¥6.83
EPS
-CNÂ¥0.00
Shares outstanding
160.00M
No. of employees
1K
News stories
From web sources and news partners
About Zhejiang Ausun Pharmaceutical Co Ltd
CEO-
Employees1.33K
FoundedApr 22, 2010
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteausunpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
146.80M
308.67M
158.94M
142.64M
Cost of goods sold
109.90M
116.10M
101.33M
85.87M
Cost of revenue
109.90M
116.10M
101.33M
85.87M
Research and development expenses
86.27M
30.76M
27.11M
60.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.63M
25.16M
27.55M
29.65M
Operating expense
122.51M
65.26M
64.56M
70.55M
Total operating expenses
232.42M
181.36M
165.89M
156.43M
Operating income
-85.62M
127.32M
-6.95M
-13.78M
Other non operating income
4.51M
-24.03M
23.70M
-45.07M
EBT including unusual items
-95.44M
107.33M
22.96M
-58.36M
EBT excluding unusual items
-91.98M
110.40M
-10.81M
-23.22M
Income tax expense
-18.98M
10.67M
-214.34K
-10.45M
Effective tax rate
19.89%
9.94%
-0.93%
17.91%
Other operating expenses
-1.11M
-1.44M
5.70M
-4.59M
Net income
-76.46M
96.66M
23.18M
-47.91M
Net profit margin
-52.09%
31.32%
14.58%
-33.59%
Earnings per share
-
-
-
-
Interest and investment income
12.21M
9.94M
12.70M
5.41M
Interest expense
-2.47M
-2.83M
-2.59M
-7.45M
Net interest expenses
9.74M
7.12M
10.11M
-2.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-67.40M
145.53M
13.96M
4.43M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps